Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island

Addiction

Volumn 107, Issue 8, 2012, Pages 1471-1479

  Friguls, Bibiana ^a,b,c,d   Joya, Xavier ^a,d   Garcia Serra, Joan ^c,e   Gómez Culebras, Mario ^f   Pichini, Simona ^g   Martinez, Susana ^a,c   Vall, Oriol ^a,b,c,d   Garcia Algar, Oscar ^a,b,c,d  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b Paediatric Department   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL CAN MISSES   (Spain)

^f Universidad de Tenerife   (Spain)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Alcohol; Biomarkers; Cannabis; Cocaine; Drugs of abuse; Hair; Ibiza; Pregnancy

Indexed keywords

BIOLOGICAL MARKER; STREET DRUG;

ADDICTION; ADULT; ARTICLE; CHEMISTRY; FEMALE; HAIR; HUMAN; MASS FRAGMENTOGRAPHY; METHODOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PREVALENCE; PROSPECTIVE STUDY; SOUTHERN EUROPE; SPAIN; SUBSTANCE ABUSE;

ADULT; BIOLOGICAL MARKERS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HAIR; HUMANS; MEDITERRANEAN ISLANDS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PREVALENCE; PROSPECTIVE STUDIES; SPAIN; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 84863782457     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.03828.x     Document Type: Article

References (44)

1. European Monitoring Centre for Drugs and Drug Addiction. General population surveys (GPS). 2011. Available at: (accessed 26 April 2011).
2. Levy M., Koren G. Obstetric and neonatal effects of drugs of abuse. Emerg Med Clin North Am 1990; 8: 633-52.
3. Schempf A. H. Illicit drug use and neonatal outcomes: a critical review. Obstet Gynecol Surv 2007; 62: 749-57.
4. Shankaran S., Lester B. M., Das A., Bauer C. R., Bada H. S., Lagasse L. etal. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med 2007; 12: 143-50.
5. Chasnoff I. J., Bussey M. E., Savich R., Stack C. M. Perinatal cerebral infarction and maternal cocaine use. J Pediatr 1986; 108: 456-9.
6. Chasnoff I. J., Griffith D. R. Cocaine: clinical studies of pregnancy and the newborn. Ann NY Acad Sci 1989; 562: 260-6.
7. Ellis J. E., Byrd L. D., Sexson W. R., Patterson-Barnett C. A. In utero exposure to cocaine: a review. South Med J 1993; 86: 725-31.
8. de Moraes M. C., Guinsburg R., de Araújo C., Mitsuhiro S., Chalem E., Laranjeira R. R. Exposure to marijuana during pregnancy alters neurobehavior in the early neonatal period. J Pediatr 2006; 149: 781-7.
9. Winklbaur B., Jung E., Fischer G. Opioid dependence and pregnancy. Curr Opin Psychiatry 2008; 21: 255-9.
10. Sokol R. J., Delaney-Black V., Nordstrom B. Fetal alcohol spectrum disorder. JAMA 2003; 290: 2996-9.
11. Andres R. L., Day M. C. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000; 5: 231-41.
12. Gillogley K. M., Evans A. T., Hansen R. L., Samuels S. J., Batra K. K. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 1990; 163: 1535-42.
13. Ostrea E. M., Brady M., Gause S., Raymundo A. L., Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992; 89: 107-13.
14. Birchfield M., Scully J., Handler A. Perinatal screening for illicit drugs: policies in hospitals in a large metropolitan area. J Perinatol 1995; 15: 208-14.
15. Lester B. M., ElSohly M., Wright L. L., Smeriglio V. L., Verter J., Bauer C. R. etal. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 2001; 107: 309-17.
16. Bar-Oz B., Klein J., Karaskov T., Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003; 88: F98-100.
17. Farkas A. G., Colbert D. L., Erskine K. J. Anonymous testing for drug abuse in an antenatal population. Br J Obstet Gynaecol 1995; 102: 563-5.
18. Bosio P., Keenan E., Gleeson R., Dorman A., Clarke T., Darling M. etal. The prevalence of chemical substance and alcohol abuse in an obstetric population in Dublin. Ir Med J 1997; 90: 149-50.
19. Sherwood R. A., Keating J., Kavvadia V., Greenough A., Peters T. J. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr 1999; 158: 488-92.
20. Sanaullah F., Gillian M., Lavin T. Screening of substance misuse during early pregnancy in Blyth: an anonymous unlinked study. J Obstet Gynaecol 2006; 26: 187-90.
21. Garcia-Algar O., Vall O., Puig C., Mur A., Scaravelli G., Pacifici R. etal. [Prenatal exposure to drugs of abuse using meconium analysis in a low socioeconomic population in Barcelona]. An Pediatr (Barc) 2009; 70: 151-8.
22. Klein J., Karaskov T., Koren G. Clinical applications of hair testing for drugs of abuse-the Canadian experience. Forensic Sci Int 2000; 107: 281-8.
23. Kintz P., Villain M., Cirimele V. Hair analysis for drug detection. Ther Drug Monit 2006; 28: 442-6.
24. DiGregorio G. J., Ferko A. P., Barbieri E. J., Ruch E. K., Chawla H., Keohane D. etal. Determination of cocaine usage in pregnant women by a urinary EMIT drug screen and GC-MS analyses. J Anal Toxicol 1994; 18: 247-50.
25. Ostrea E. M., Knapp D. K., Tannenbaum L., Ostrea A. R., Romero A., Salari V. etal. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001; 138: 344-8.
26. Garcia-Bournissen F., Rokach B., Karaskov T., Koren G. Cocaine detection in maternal and neonatal hair: implications to fetal toxicology. Ther Drug Monit 2007; 29: 71-6.
27. Calafat A., Juan B. K., Kokkevi A., Maalste N., Mende F., Palmer A. Nightlife in Europe and recreative drug use. Palma de Mallorca: Istituto di Ricerca Europeo sui Fattori di Rischio nell'Infanzia e nell'Adolescenza (IREFREA) and European Commission, 1999.
28. Pichini S., Puig C., Zuccaro P., Marchei E., Pellegrini M., Murillo J. etal. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the 'Meconium Project'. Forensic Sci Int 2005; 153: 59-65.
29. Pichini S., Pacifici R., Altieri I., Pellegrini M., Zuccaro P. Determination of opiates and cocaine in hair as trimethylsilyl derivatives using gas chromatography-tandem mass spectrometry. J Anal Toxicol 1999; 23: 343-8.
30. Govern de les Illes Balears. Cultura i societat. 2011. Available at: (accessed 26 April 2011; archived at).
31. Society of Hair Testing. Recommendations for hair testing in forensic cases. Forensic Sci Int 2004; 145: 83-4.
32. Yawn B. P., Thompson L. R., Lupo V. R., Googins M. K., Yawn R. A. Prenatal drug use in Minneapolis-St Paul, Minn. A 4-year trend. Arch Fam Med 1994; 3: 520-7.
33. Williamson S., Jackson L., Skeoch C., Azzim G., Anderson R. Determination of the prevalence of drug misuse by meconium analysis. Arch Dis Child Fetal Neonatal Ed 2006; 91: F291-2.
34. Koren G., Klein J., Forman R., Graham K. Hair analysis of cocaine: differentiation between systemic exposure and external contamination. J Clin Pharmacol 1992; 32: 671-5.
35. Kline J., Ng S. K., Schittini M., Levin B., Susser M. Cocaine use during pregnancy: sensitive detection by hair assay. Am J Public Health 1997; 87: 352-8.
36. Ministerio de Sanidad y Política Social. Observatorio Español sobre Drogas. 2009. Available at: (accessed 26 April 2011; archived at).
37. Mitsuhiro S. S., Chalem E., Barros M. C., Guinsburg R., Laranjeira R. Prevalence of cocaine and marijuana use in the last trimester of adolescent pregnancy: socio-demographic, psychosocial and behavioral characteristics. Addict Behav 2007; 32: 392-7.
38. Chiarotti M., Strano-Rossi S., Offidani C., Fiori A. Evaluation of cocaine use during pregnancy through toxicological analysis of hair. J Anal Toxicol 1996; 20: 555-8.
39. Bellis M. A., Hughes K., Calafat A., Juan M., Schnitzer S. Relative contributions of holiday location and nationality to changes in recreational drug taking behaviour: a natural experiment in the Balearic Islands. Eur Addict Res 2009; 15: 78-86.
40. Direcció General de Salut Pública i Consum. Govern de les Illes Balears. Sistema estatal d'informació permanent sobre addicció a drogues (SEIPAD). Indicador d'urgències hospitalàries en consumidors de substàncies psicoactives. Resultats d'Eivissa de l'any 2010. Available at: (accessed 26 April 2011; archived at).
41. Lai S., Lai H., Page J. B., McCoy C. B. The association between cigarette smoking and drug abuse in the United States. J Addict Dis 2000; 19: 11-24.
42. Shor S., Nulman I., Kulaga V., Koren G. Heavy in utero ethanol exposure is associated with the use of other drugs of abuse in a high-risk population. Alcohol 2010; 44: 623-7.
43. Garcia-Algar O., Kulaga V., Gareri J. etal. Alarming prevalence of fetal alcohol exposure in a Mediterranean city. Ther Drug Monit 2008; 30: 249-54.
44. Addis A., Moretti M. E., Ahmed F., Einarson T. R., Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 2001; 15: 341-69.